Brain‐Derived Neurotrophic Factor (BDNF) as a Potential Biomarker in Brain Glioma: A Systematic Review and Meta‐Analysis
Brain and Behavior · 2025-01 · 15 (1)
DOI: 10.1002/brb3.70266 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Brain and Behavior, online erschienen am 09.01.2025. Verfasst von Fatemeh Hasani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology and Hepatology Research Center, Golestan University of Medical Sciences, Gorgan, Iran. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Brain Neoplasms, Brain-Derived Neurotrophic Factor, Glioma. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
This systematic review and meta‐analysis evaluates peripheral and CNS BDNF levels in glioma patients.
Methods
Following PRISMA guidelines, we systematically searched databases for studies measuring BDNF in glioma patients and controls. After screening and data extraction, we conducted quality assessment, meta‐analysis, and meta‐regression.
Results
Eight studies were included. Meta‐analysis showed significantly reduced plasma BDNF levels in glioma patients versus controls (SMD: −1.0026; 95% CI: [−1.5284, −0.4769], p = 0.0002). High‐grade gliomas had lower plasma BDNF ( p = 0.0288). Tissue BDNF levels were higher in glioma patients (SMD: 1.9513; 95% CI: [0.7365, 3.1661], p = 0.0016) and correlated with tumor grade ( p = 0.0122). Plasma BDNF levels negatively correlated with patient age ( p = 0.0244) and positively with female percentage ( p = 0.0007).
Conclusion
BDNF is a promising biomarker in glioma, showing significant changes in plasma and tissue levels correlating with tumor grade, patient age, and gender.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gastroenterology and Hepatology Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
- Neuroscience Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
- School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
- Student Research Committee, Faculty of Medicine, Medical University of Qom, Qom, Iran.
- School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
- Biggs Institute, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
ORCID-Profile: Fatemeh Hasani
Zitieren
APA
Hasani, F., Masrour, M., Khamaki, S., Jazi, K., Ghoodjani, E., & Teixeira, A. L. (2025). Brain‐Derived Neurotrophic Factor (BDNF) as a Potential Biomarker in Brain Glioma: A Systematic Review and Meta‐Analysis. Brain and Behavior, 15(1). https://doi.org/10.1002/brb3.70266
Vancouver
Hasani F, Masrour M, Khamaki S, Jazi K, Ghoodjani E, Teixeira AL. Brain‐Derived Neurotrophic Factor (BDNF) as a Potential Biomarker in Brain Glioma: A Systematic Review and Meta‐Analysis. Brain and Behavior. 2025;15(1). doi:10.1002/brb3.70266
BibTeX
@article{Hasani2025,
author = {Hasani, Fatemeh and Masrour, Mahdi and Khamaki, Sina and Jazi, Kimia and Ghoodjani, Erfan and Teixeira, Antonio L},
title = {Brain‐Derived Neurotrophic Factor (BDNF) as a Potential Biomarker in Brain Glioma: A Systematic Review and Meta‐Analysis},
journal = {Brain and Behavior},
year = {2025},
volume = {15},
number = {1},
doi = {10.1002/brb3.70266}
}
EUVIMED